Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Complement Altern Med ; 17(1): 355, 2017 Jul 05.
Artigo em Inglês | MEDLINE | ID: mdl-28679382

RESUMO

BACKGROUND: Natural products have many uses and purposes, including those linked to pharmaceutics and cosmetics. The aim of this study was to investigate the use of natural remedies for the treatment of hair and scalp disorders in the West Bank, Palestine. METHODS: An ethnopharmacological survey of herbal remedies and other natural products used in cosmetics and cosmeceuticals was carried out in the West Bank, Palestine. A questionnaire was distributed to 267 herbalists, traditional healers, hairdressers and rural dwellers. Collected information included: the names of plants and other natural products, the parts used, hair conditions, diseases and problems for which these products were used and also their methods of preparation. To identify the most important species used, the factor of informant's consensus (Fic), fidelity level (Fl) and the use-value (UV) were calculated. RESULTS: Collected data showed that 41 plants are utilized for the treatment of hair and scalp disorders, belonging to 27 families; among them Lamiaceae and Rosaceae, which were the most commonly used. Plant oils and their fruits are the most commonly used parts. Hair loss, dandruff, split hair endings and lice treatment, are reported as the most treated disorders. The number of plant species used consisted of 19, 14, 13, and again 13 with a factor of informant's consensus (Fic) for these disorders corresponding to 0.93, 0.94, 0.95 and 0.92, respectively. Fl was 100% for many plants; the highest UV value (0.84) was registered for Lawsonia inermis, which belongs to the Lythraceae family. CONCLUSIONS: This study showed that many natural remedies are still used in Palestine for the treatment of scalp and hair disorders as well as for cosmeceutical purposes. This study is of great importance as it allows us to have a greater perspective on our folkloric use of these natural products. A combined scientific effort between informants and the scientific community, working in this field, may help in the discovery of new cosmetics, cosmeceutical and nutraceutical products.


Assuntos
Etnofarmacologia , Doenças do Cabelo/tratamento farmacológico , Medicina Tradicional/estatística & dados numéricos , Preparações de Plantas/uso terapêutico , Dermatoses do Couro Cabeludo/tratamento farmacológico , Adolescente , Adulto , Composição de Medicamentos , Feminino , Cabelo/efeitos dos fármacos , Doenças do Cabelo/etnologia , Humanos , Masculino , Pessoa de Meia-Idade , Oriente Médio/etnologia , Preparações de Plantas/química , Dermatoses do Couro Cabeludo/etnologia , Adulto Jovem
2.
J Dermatolog Treat ; 25(1): 38-45, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23083439

RESUMO

BACKGROUND: International consensus statements on the management of scalp psoriasis are available, but no such recommendations exist for Asia. METHODS: The Asia Scalp Psoriasis Study Group (ASPSG) met in May 2011 to review the epidemiologic pattern of scalp psoriasis in Southeast Asia and to develop Asia-specific recommendations for its management. RESULTS: The overall prevalence of psoriasis in Asia is <0.3%, but 75-90% have scalp involvement, whether isolated or with lesions elsewhere, which can negatively impact quality of life (QoL). Treatment decisions should be based primarily on objective disease severity, but should also take account of patient QoL. Psychosocial support and more aggressive treatment should be offered to all patients with moderate to severe QoL impairment. Topical therapy is indicated first-line in all patients, with combination therapy (corticosteroid + calcipotriol), more occlusive formulations, keratolytics, and very potent corticosteroids for patients needing greater or faster efficacy. Systemic therapies, light or laser treatments should be reserved for patients with severe and recalcitrant disease. CONCLUSIONS: The ASPSG recommends a patient-centered approach to scalp psoriasis management, consistent with the international consensus statements. Asian physicians should also consider patient QoL, prior treatment response, formulation preferences, likely adherence, cost, time available for self-management, and potential adverse events.


Assuntos
Fármacos Dermatológicos/administração & dosagem , Assistência Centrada no Paciente/métodos , Fototerapia/métodos , Psoríase/terapia , Dermatoses do Couro Cabeludo/terapia , Administração Cutânea , Corticosteroides/administração & dosagem , Adulto , Idade de Início , Ásia , Consenso , Feminino , Humanos , Malassezia/isolamento & purificação , Masculino , Psoríase/etnologia , Psoríase/microbiologia , Psoríase/patologia , Qualidade de Vida , Dermatoses do Couro Cabeludo/etnologia , Dermatoses do Couro Cabeludo/microbiologia , Dermatoses do Couro Cabeludo/patologia , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA